Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo

Oncology Research

Volumn 20, Issue 7, 2013, Pages 303-317

  Nickerson, Nicole K ^a   Mill, Christopher P ^b,c   Wu, Hsin Jung ^a   Riese II, David J ^b,d   Foley, John ^a,e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AUBURN UNIVERSITY   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d PURDUE UNIVERSITY   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphiregulin; Breast cancer; Epidermal growth factor receptor ((EGFR); Macrophage colony stimulating factor 1 (MCSF 1); Transforming growth factor (TGF )

Indexed keywords

AMPHIREGULIN; CHEMOATTRACTANT; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 84878937536     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13639794277761     Document Type: Article

References (54)

1. Yarden, Y.; Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2:127-137; 2001.
2. Nguyen, D. X.; Bos, P. D.; Massague, J. Metastasis: From dissemination to organ-specific colonization. Nat. Rev. Cancer 9:274-284; 2009.
3. Carpenter, G.; Cohen, S. Epidermal growth factor. J. Biol. Chem. 265:7709-7712; 1990.
4. Shoyab, M.; Plowman, G. D.; McDonald, V. L.; Bradley, J. G.; Todaro, G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243:1074-1076; 1989.
5. Derynck, R. The physiology of transforming growth factor-α. Adv. Cancer Res. 58:27-52; 1992.
6. Higashiyama, S.; Abraham, J. A.; Miller, J.; Fiddes, J. C.; Klagsbrun, M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939; 1991.
7. Riese, 2nd., D. J.; Bermingham, Y.; van Raaij, T. M.; Buckley, S.; Plowman, G. D.; et al. β-cellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β. Oncogene 12:345-353; 1996.
8. Toyoda, H.; Komurasaki, T.; Uchida, D.; Takayama, Y.; Isobe, T.; et al. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem. 270:7495-7500; 1995.
9. Sahin, U.; Weskamp, G.; Kelly, K.; Zhou, H. M.; Higashiyama, S.; et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769-779; 2004.
10. Ellis, I. R.; Schor, A. M.; Schor, S. L. EGF AND TGF-α motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms. Exp. Cell Res. 313: 732-741; 2007.
11. Roepstorff, K.; Grandal, M. V.; Henriksen, L.; Knudsen, S. L.; Lerdrup, M.; et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic 10:1115-1127; 2009.
12. Silva, C. M. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23:8017-8023; 2004.
13. Wilson, K. J.; Gilmore, J. L.; Foley, J.; Lemmon, M. A.; Riese, 2nd., D. J. Functional selectivity of EGF family peptide growth factors: Implications for cancer. Pharmacol. Ther. 122:1-8; 2009.
14. Elenius, K.; Paul, S.; Allison, G.; Sun, J.; Klagsbrun, M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16:1268-1278; 1997.
15. Willmarth, N. E.; Baillo, A.; Dziubinski, M. L.; Wilson, K.; Riese, 2nd., D. J.; et al. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell. Signal. 21:212-219; 2009.
16. Stern, K. A.; Place, T. L.; Lill, N. L. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate. Biochem. J. 410:585-594; 2008.
17. Komurasaki, T.; Toyoda, H.; Uchida, D.; Morimoto, S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 15:2841-2848; 1997.
18. Kochupurakkal, B. S.; Harari, D.; Di-Segni, A.; Maik-Rachline, G.; Lyass, L.; et al. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J. Biol. Chem. 280:8503-8512; 2005.
19. Citri, A.; Yarden, Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell. Biol. 7:505-516; 2006.
20. Marmor, M. D.; Yarden, Y. Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23:2057-2070; 2004.
21. Wilson, K. J.; Mill, C.; Lambert, S.; Buchman, J.; Wilson, T. R.; et al. EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors 30:107-116; 2012.
22. van't Veer, L. J.; Dai, H.; van de Vijver, M. J.; He, Y. D.; Hart, A. A.; et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536; 2002.
23. Kenny, P. A.; Bissell, M. J. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest. 117:337-345; 2007.
24. Burness, M. L.; Grushko, T. A.; Olopade, O. I. Epidermal growth factor receptor in triple-negative and basal-like breast cancer: Promising clinical target or only a marker? Cancer J. 16:23-32; 2010.
25. Roda, J. M.; Sumner, L. A.; Evans, R.; Phillips, G. S.; Marsh, C. B.; et al. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. J. Immunol. 187:1970-1976; 2011.
26. Voloshin, T.; Gingis-Velitski, S.; Bril, R.; Benayoun, L.; Munster, M.; et al. G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist. Blood 18:3425-3435; 2011.
27. Leek, R. D.; Harris, A. L. Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7: 177-189; 2002.
28. Goswami, S.; Sahai, E.; Wyckoff, J. B.; Cammer, M.; Cox, D.; et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65:5278-5283; 2005.
29. Patsialou, A.; Wyckoff, J.; Wang, Y.; Goswami, S.; Stanley, E. R.; et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res. 69:9498-9506; 2009.
30. Philippar, U.; Roussos, E. T.; Oser, M.; Yamaguchi, H.; Kim, H. D.; et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev. Cell 15:813-828; 2008.
31. Nickerson, N. K.; Mohammad, K. S.; Gilmore, J. L.; Crismore, E.; Bruzzaniti, A.; et al. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. PLoS One 7:e30255; 2012.
32. Cataisson, C.; Gordon, J.; Roussiere, M.; Abdalkhani, A.; Lindemann, R.; et al. Ets-1 activates parathyroid hormone-related protein gene expression in tumorigenic breast epithelial cells. Mol. Cell. Endocrinol. 204:155-168; 2003.
33. Cataisson, C.; Lieberherr, M.; Cros, M.; Gauville, C.; Graulet, A. M.; et al. Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells. J. Bone Miner. Res. 15:2129-2139; 2000.
34. Cho, Y. M.; Lewis, D. A.; Koltz, P. F.; Richard, V.; Gocken, T. A.; et al. Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes. J. Endocrinol. 181:179-190; 2004.
35. Strachan, L.; Murison, J. G.; Prestidge, R. L.; Sleeman, M. A.; Watson, J. D.; et al. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem. 276:18265-18271; 2001.
36. Wu, W. K.; Tse, T. T.; Sung, J. J.; Li, Z. J.; Yu, L.; et al. Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines. Anticancer Res. 29: 229-234; 2009.
37. Kwon, Y. J.; Hurst, D. R.; Steg, A. D.; Yuan, K.; Vaidya, K. S.; et al. Gli1 enhances migration and invasion via upregulation of MMP-11 and promotes metastasis in ERa negative breast cancer cell lines. Clin. Exp. Metastasis 28: 437-449; 2011.
38. Ashton-Key, M.; Jessup, E.; Isaacson, P. G. Immunoglobulin light chain staining in paraffin-embedded tissue using a heat mediated epitope retrieval method. Histopathology 29: 525-531; 1996.
39. Gilmore, J. L.; Scott, J. A.; Bouizar, Z.; Robling, A.; Pitfield, S. E. et al. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res. Treat. 110:493-505; 2008.
40. Hirsch, D. S.; Shen, Y.; Wu, W. J. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. Cancer Res. 66:3523-3530; 2006.
41. Wilhelm, S. M.; Collier, I. E.; Marmer, B. L.; Eisen, A. Z.; Grant, G. A.; et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type 4 collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213-17221; 1989.
42. Davis, G. E.; Martin, B. M. A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: A member of the collagenase family of enzymes. Cancer Res. 50:1113-1120; 1990.
43. Davidson, N. E.; Gelmann, E. P.; Lippman, M. E.; Dickson, R. B. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol. 1:216-223; 1987.
44. Price, J. T.; Tiganis, T.; Agarwal, A.; Djakiew, D.; Thompson, E. W. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res. 59:5475-5478; 1999.
45. Mizutani, K.; Sud, S.; McGregor, N. A.; Martinovski, G.; Rice, B. T.; et al. The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 11:1235-1242; 2009.
46. Lu, X.; Kang, Y. Chemokine (C-C motif) ligand 2 engages CCR2 + stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J. Biol. Chem. 284:29087-29096; 2009.
47. Qian, B. Z.; Li, J.; Zhang, H.; Kitamura, T.; Zhang, J.; et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222-225; 2011.
48. Barnard, J. A.; Graves-Deal, R.; Pittelkow, M. R.; DuBois, R.; Cook, P.; et al. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 269:22817-22822; 1994.
49. Katz, M.; Shtiegman, K.; Tal-Or, P.; Yakir, L.; Mosesson, Y.; et al. Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic 3:740-751; 2002.
50. Konstantinopoulos, P. A.; Vandoros, G. P.; Karamouzis, M. V.; Gkermpesi, M.; Sotiropoulou-Bonikou, G.; et al. EGF-R is expressed and AP-1 and NF-kappaB are activated in stromal myofibroblasts surrounding colon adenocarcinomas paralleling expression of COX-2 and VEGF. Cell. Oncol. 29:477-482; 2007.
51. Amin, D. N.; Hida, K.; Bielenberg, D. R.; Klagsbrun, M. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res. 66:2173-2180; 2006.
52. Cook, P. W.; Damm, D.; Garrick, B. L.; Wood, K. M.; Karkaria, C. E.; et al. Carboxyl-terminal truncation of leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor. J. Cell Physiol. 163:407-417; 1995.
53. Adam, R.; Drummond, D. R.; Solic, N.; Holt, S. J.; Sharma, R. P.; et al. Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. Biochim. Biophys. Acta 1266:83-90; 1995.
54. Voloshin, T.; Gingis-Velitski, S.; Bril, R.; Benayoun, L.; Munster, M.; et al. G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: Prevention by a CXCR4 antagonist. Blood 118:3426-3435; 2011.